# Mastoiditis

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD05.02 - condition scope only, no dose · Mastoiditis - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK560877/ · Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)
- Verified date: 2026-08

## Verified against

- Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)

## Treatment metadata

- Ceftriaxone — 1000 mg — injection
- Referral & safety-netting (no drug therapy)

## Complete treatment card

```text
MASTOIDITIS
Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD05.02 -
         condition scope only, no dose · Mastoiditis - StatPearls - NCBI Bookshelf -
         https://www.ncbi.nlm.nih.gov/books/NBK560877/ · Egyptian National Drug Formulary -
         Antimicrobial 2023 (ceftriaxone monograph, p255)
Review status: REVIEWED against the source listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (6)
    - Young children under two often present with irritability, fussiness, lethargy, fever, ear
      pulling, and ear pain  [ear pain · fever · irritability · lethargy]
    - In adults, severe ear pain with fever and a headache is the typical complaint  [ear pain ·
      fever · headache]
    - It is almost always a complication of an acute middle ear infection
    - Children catch middle ear infections more readily, so they are the ones who get this
    - Red flag: left untreated it ends in meningitis, an abscess inside the skull, or a clot in a
      venous sinus  [abscess]
    - Red flag: even now, one in ten children who reach those complications dies of them
  SIGNS - what you find (3)
    - Redness, tenderness, warmth, and fluctuance behind the ear with the auricle pushed forward
      [redness]
    - Otoscopy shows bulging of the back-upper canal wall and a bulging, pus-filled eardrum,
      sometimes ruptured and draining  [pus]
    - A normal-looking eardrum usually, though not always, rules out acute mastoiditis
  TESTS (3)
    - CBC typically shows a raised white cell count with a left shift, plus raised ESR and CRP
    - CT can show loss of the bony walls between mastoid air cells
    - CT may show thickened or disrupted periosteum, or a collection beneath it (subperiosteal
      abscess)
  IF NOT THIS - what else fits (3)
    - Tumors mimicking mastoiditis are more often bilateral, involve cranial nerves, and less often
      cause fever
    - Cellulitis, otitis externa, lymphadenopathy, trauma, and tumor can all mimic acute mastoiditis
    - Rarely the air cells alone are infected, called incipient mastoiditis, or a grumbling middle
      ear gives the subacute form
  Source  StatPearls "Mastoiditis" - disease-level clinical article
  Status  traced to the source above

Rx: Antibiotic  |  Main treatment

ANTIBIOTIC
1. CEFTRIAXONE                                            [1st line]
   Adult    1-2 g once daily by intravenous or intramuscular injection - Reviewed at 48 hours -
            failure to improve by then is an indication for mastoidectomy
   Peds     50-75 mg/kg/dose  [child max 1000 mg]
            (Infants, children and adolescents, mild to moderate infection:
            50-75 mg/kg as a single daily dose, maximum 1,000 mg a day. Severe
            infection: 100 mg/kg/day divided every 12 to 24 hours, maximum
            4,000 mg/day.)
            3kg -> 150-225 mg/dose                   4kg -> 200-300 mg/dose
            5kg -> 250-375 mg/dose                   6kg -> 300-450 mg/dose
            7kg -> 350-525 mg/dose                   8kg -> 400-600 mg/dose
            9kg -> 450-675 mg/dose                   10kg -> 500-750 mg/dose
            11kg -> 550-825 mg/dose                  12kg -> 600-900 mg/dose
            13kg -> 650-975 mg/dose                  14kg -> 700-1000 mg/dose (upper capped)
            15kg -> 750-1000 mg/dose (upper capped)  16kg -> 800-1000 mg/dose (upper capped)
            17kg -> 850-1000 mg/dose (upper capped)  18kg -> 900-1000 mg/dose (upper capped)
            19kg -> 950-1000 mg/dose (upper capped)  20kg -> 1000 mg/dose (capped)
            21kg -> 1000 mg/dose (capped)            22kg -> 1000 mg/dose (capped)
            23kg -> 1000 mg/dose (capped)            24kg -> 1000 mg/dose (capped)
            25kg -> 1000 mg/dose (capped)            26kg -> 1000 mg/dose (capped)
            27kg -> 1000 mg/dose (capped)            28kg -> 1000 mg/dose (capped)
            29kg -> 1000 mg/dose (capped)            30kg -> 1000 mg/dose (capped)
            31kg -> 1000 mg/dose (capped)            32kg -> 1000 mg/dose (capped)
            33kg -> 1000 mg/dose (capped)            34kg -> 1000 mg/dose (capped)
            35kg -> 1000 mg/dose (capped)            36kg -> 1000 mg/dose (capped)
            37kg -> 1000 mg/dose (capped)            38kg -> 1000 mg/dose (capped)
            39kg -> 1000 mg/dose (capped)            40kg -> 1000 mg/dose (capped)
            41kg -> 1000 mg/dose (capped)            42kg -> 1000 mg/dose (capped)
            43kg -> 1000 mg/dose (capped)            44kg -> 1000 mg/dose (capped)
            45kg -> 1000 mg/dose (capped)            46kg -> 1000 mg/dose (capped)
            47kg -> 1000 mg/dose (capped)            48kg -> 1000 mg/dose (capped)
            49kg -> 1000 mg/dose (capped)            50kg -> 1000 mg/dose (capped)
   AWaRe    WATCH group - carries resistance cost. Egyptian EML 2025.
   Source   Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)
   Why      The cited article says antibiotics are the centrepiece of treatment, that most patients
            with acute mastoiditis are admitted, and that the uncomplicated patient with no
            significant history has been treated successfully as an outpatient on daily intravenous
            ceftriaxone with a low complication rate. The formulary's ceftriaxone monograph names
            acute otitis media - the infection mastoiditis grows out of - among its indications and
            gives the paediatric weight rule below. Antibiotics alone still leave an 8.5%
            complication rate in the article's figures, which is why this drug goes with a referral
            and not instead of one.
   Caution  SEND THE PATIENT IN. The article says most patients with acute mastoiditis are admitted,
            and that a myringotomy with a grommet, or a mastoidectomy, may be needed alongside the
            antibiotic.
            REVIEW AT 48 HOURS. The article says mastoidectomy is indicated if mastoiditis has not
            improved by then, and warns that the clinical state can deteriorate quickly - serial
            examination, not one look.
            WHAT MAKES IT COMPLICATED, in the article's words: a large lesion behind the ear, bone
            erosion on imaging, high fever, or any neurological sign. Any of these and outpatient
            treatment is off the table.
            The article's own first choice for the inpatient without chronic otitis media is
            intravenous vancomycin alone, with an anti-pseudomonal drug added where there is a long
            history of ear infection. Neither the article nor the Egyptian formulary states a
            vancomycin dose, so no vancomycin row is printed here - that dose has to come from the
            admitting unit.
            Do not give to anyone with a known allergy to ceftriaxone or another cephalosporin.
            Never with an intravenous calcium-containing fluid in a baby of 28 days or under, and
            not in a jaundiced newborn.
   Egypt    ZOXIDEL 1 GM PD. FOR I.M. INJ.   RAMEDA > DELT...    22.00 EGP
            CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA) KAHIRA                               29.00 EGP
            ZOXIDEL 1 GM PD. FOR I.V. INJ.   RAMEDA > DELT...    29.00 EGP
            WINTRIAXONE 1 GM PD. FOR I.V INJ. SANOFI                                       48.00 EGP
            VOTRIAXONE 1 GM I.M VIAL         CHEMIPHARM          56.00 EGP
            OFRAMAX 1 GM I.M. VIAL           RAMEDA > SUN ...    71.00 EGP
            TRIAXONE 1 GM I.M. VIAL          TABUK PHARMAC...   106.00 EGP
            TRIAXONE 1 GM I.V VIAL           TABUK PHARMAC...   106.00 EGP


MAIN TREATMENT
2. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)            [1st line]
   Adult    Acute mastoiditis is a potentially life-threatening suppurative complication of acute
            otitis media that requires immediate same-day hospital admission rather than outpatient
            oral antibiotic therapy. Key clinical signs include retroauricular erythema, warmth,
            fluctuant swelling (subperiosteal abscess), tenderness over the mastoid process, and
            outward/downward displacement of the pinna. Arrange urgent emergency transport for high-
            dose intravenous broad-spectrum antibiotics, urgent temporal bone CT imaging, and ENT
            surgical intervention (myringotomy, subperiosteal abscess drainage, or cortical
            mastoidectomy) to prevent lethal intracranial spread. - Refer, with advice
   Peds     Children follow the same pathway: recognise and refer. No primary-care medicine is
            implied.
   Source   No dose - referral pathway, no medicine given in primary care
   Why      Acute mastoiditis is a potentially life-threatening suppurative complication of acute
            otitis media that requires immediate same-day hospital admission rather than outpatient
            oral antibiotic therapy. Key clinical signs include retroauricular erythema, warmth,
            fluctuant swelling (subperiosteal abscess), tenderness over the mastoid process, and
            outward/downward displacement of the pinna. Arrange urgent emergency transport for high-
            dose intravenous broad-spectrum antibiotics, urgent temporal bone CT imaging, and ENT
            surgical intervention (myringotomy, subperiosteal abscess drainage, or cortical
            mastoidectomy) to prevent lethal intracranial spread.
   Caution  The drug rows above are what the treating service gives. They are here so that the
            referral is an informed one and so the GP can recognise the regimen the patient comes
            back on - not as permission to start it without the referral.
            RED FLAG - Swelling or redness behind the ear pushing it forward, high fever with
            systemic illness, or signs of intracranial spread such as severe headache, neck
            stiffness, or altered consciousness.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
